Key Takeaways
- Disney announced a $1 billion investment and three-year licensing deal with OpenAI.
- Oracle's shares dropped nearly 11% due to investor concerns about AI infrastructure spending.
- The U.S. is developing a domestic critical minerals industry, backed by Silicon Valley investment.
- Eli Lilly reported substantial weight loss results in a clinical trial for its drug, Red Atru Tide.
- Efforts to extend federal health insurance subsidies failed in the Senate before year-end.
- Bulgaria's coalition government resigned following Gen Z-led protests over corruption.
Deep Dive
- Disney announced a $1 billion investment and three-year licensing deal with OpenAI.
- The deal allows users to incorporate over 200 Disney, Marvel, Star Wars, and Pixar characters into AI-generated videos on OpenAI's Sora platform.
- This partnership aims to engage Disney with AI advancements and potentially stream AI-generated content on Disney Plus.
- Oracle's shares dropped nearly 11%, marking its largest single-day decline since January.
- The decline followed its latest earnings report, with investors concerned about significant spending on AI infrastructure.
- Concerns exist that Oracle's substantial AI investments may not yield proportional returns, impacting the NASDAQ.
- The U.S. is developing domestic sources for critical raw materials to reduce reliance on China.
- Silicon Valley venture capitalists invested a record $600 million in U.S. critical mineral startups this year.
- Companies like Brimstone are using AI to produce critical minerals such as aluminum, magnesium, and titanium from abundant rocks.
- IONIC Mineral Technologies recently discovered 16 rare earth and critical minerals in Utah, bolstering U.S. domestic supply efforts.
- Ukraine and its European allies presented a peace plan, though significant gaps remain concerning Russian-controlled territories.
- In Bulgaria, Gen Z-led protests over corruption led to the resignation of the country's coalition government.